Academic Articles & Research Papers

Exosomal circ_0000387 Is Associated With Ovarian Cancer Metastatic Regulation Through IGF2BP3-Related Signalling and Endothelial VWF Responses.

Xie Y, Shen P, Chen H, Shen Q et al. • Journal of biochemical and molecular toxicology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/jbt.71135 PMC: PMC13732641

View Article » Original Source ↗

Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer.

Wang Q, Li L, You L, Wang S et al. • eLife (2026)

PMC PMC Public Access (View-Only) DOI: 10.7554/eLife.109052 PMC: PMC13734679

View Article » Original Source ↗

Bispecific antibodies targeting B-cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions.

Manzato E, Cocchetto G, Barbato S, Puppi M et al. • Cancer (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/cncr.70641 PMC: PMC13732804

View Article » Original Source ↗

Gramicidin Inhibits Lung Cancer Metastasis by Suppressing the ABL-MMP9 Signaling Axis.

Li X, Chen L • Journal of biochemical and molecular toxicology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/jbt.71156 PMC: PMC13734286

View Article » Original Source ↗

Adjuvant mFOLFOXIRI after curative-intent resection of oligometastatic colorectal cancer: phase II FANTASTIC trial.

Kataoka K, Yamada T, Yamazaki K, Kanaka S et al. • BJS open (2026)

PMC PMC Public Access (View-Only) DOI: 10.1093/bjsopen/zrag144 PMC: PMC13733536

View Article » Original Source ↗

Cancer cells differentially modulate mitochondrial respiration to alter redox state and enable biomass synthesis in nutrient-limited environments.

Chang SM, Bin Munim M, Trojan SE, Cox H 3rd et al. • eLife (2026)

PMC PMC Public Access (View-Only) DOI: 10.7554/eLife.107123 PMC: PMC13734678

View Article » Original Source ↗

Lifestyle and dietary changes among cancer patients receiving active treatment: A cross-sectional study at a tertiary care center in Lebanon.

Farhat S, Hammoud Z, Zayour N, Fahs J et al. • PloS one (2026)

PMC PMC Public Access (View-Only) DOI: 10.1371/journal.pone.0362053 PMC: PMC13734600

View Article » Original Source ↗

IFNAR1 stabilization sustains CD8(+) T cell persistence in IFN-high colorectal cancer liver metastases.

Castiglioni A, Monestiroli A, Delfanti G, Zordan P et al. • Science advances (2026)

PMC PMC Public Access (View-Only) DOI: 10.1126/sciadv.aei0181 PMC: PMC13733802

View Article » Original Source ↗

N6-methyladenosine-dependent ARv7 translation couples lactate metabolism with enzalutamide resistance in prostate cancer.

Zhang M, Cheng B, Jia M, Li X et al. • Science advances (2026)

PMC PMC Public Access (View-Only) DOI: 10.1126/sciadv.aeg8317 PMC: PMC13733804

View Article » Original Source ↗

METTL3-mediated m(6)A modification of DNMT1 enhances ovarian cancer progression.

Kumari K, Pérez-Núñez I, Noguera Castells A, Pluvinet R et al. • Science advances (2026)

PMC PMC Public Access (View-Only) DOI: 10.1126/sciadv.aec2297 PMC: PMC13733898

View Article » Original Source ↗

Pembrolizumab Activity in Tyrosine Kinase Inhibitor-Refractory Metastatic GIST: A Case Report.

Bandaru N, Shiach J, Agulnik M • Cancer reports (Hoboken, N.J.) (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/cnr2.70726 PMC: PMC13734685

View Article » Original Source ↗

Integrated analysis identifies an aging-related prognostic signature for lung adenocarcinoma.

Zhang R, Chen X, Li N, Peng M • BMC cancer (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12885-026-16534-w PMC: PMC13732848

View Article » Original Source ↗

Assessing germline genetic testing patterns, awareness, and adherence to guidelines among lebanese prostate cancer patients.

Seif S, Najdi T, Chebly A, Bassil M et al. • BMC urology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12894-026-02300-4 PMC: PMC13733100

View Article » Original Source ↗

Pan-modification proteomics: decoding tumor heterogeneity and guiding the next generation of precision oncology.

Wang L, Yang Y, Yang JH • Cancer cell international (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12935-026-04421-0 PMC: PMC13733074

View Article » Original Source ↗

CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability.

Matvere A, Menchon G, Martinetti L, Menant A et al. • Molecular cancer (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12943-026-02757-9 PMC: PMC13732929

View Article » Original Source ↗

Cancer nanovaccine plus doxorubicin and immune checkpoint blockade overcomes chemoresistance and delays postsurgical recurrence.

Lee CM, Kwon YK, Won JE, Lee JH et al. • Journal of nanobiotechnology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12951-026-04892-3 PMC: PMC13732938

View Article » Original Source ↗

Erianin suppresses prostate cancer progression and attenuates STAT3 signaling.

Yue Z, Zhao Y, Wang J, Wang F et al. • Frontiers in oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fonc.2026.1975408 PMC: PMC13730896

View Article » Original Source ↗

From cancer safety signals to cardio-oncology translation: a dual-database bibliometric and BERTopic semantic analysis of SGLT2 inhibitor research in oncology (2014-2026).

Tang X, Niu W, Lan Z, Zhong Z • Frontiers in oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fonc.2026.1969057 PMC: PMC13730858

View Article » Original Source ↗

Knowledge, awareness, attitudes and practice regarding oral potentially malignant disorders and oral cancer among health professional students in Riyadh, Saudi Arabia: a multicenter cross-sectional study.

Khanagar SB, Alofi A, Alzaaqi LA, Alsubaie JM et al. • Frontiers in oral health (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/froh.2026.1942387 PMC: PMC13731213

View Article » Original Source ↗

Eribulin mesylate in combination with ivonescimab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer(EMIT): study protocol for a single-arm, multicenter clinical trial.

Lu H, Wang X, Wang Z, Chen M et al. • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1927990 PMC: PMC13731347

View Article » Original Source ↗